Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

计划入组 20 人 · 首次发布于 2014 年 7 月 22 日

HIV Treatment-Readiness Measure (HTRM) Validation

计划入组 200 人 · 首次发布于 2008 年 5 月 29 日

‘LASER-TBM’ Linezolid, ASpirin and Enhanced dose Rifampicin in HIV-TBM

计划入组 100 人

HTBZ

ATBM-36M

ATBM-14M

HBM Pharma s.r.o.

Slovakia

Gene-Edited Pig Kidney Functions in Macaque for Over Six Months in Chinese Study

Genetically Engineered Pig Heart Transplants Show Promise and Challenges in Xenotransplantation

HBM Alpha Therapeutics Secures $395M Licensing Deal for Novel CAH Treatment